NLS Pharmaceutics (NLS Pharmaceutics) Price-to-Operating-Cash-Flow : (As of Jun. 01, 2024)

View and export this data going back to 2021. Start your Free Trial

What is NLS Pharmaceutics Price-to-Operating-Cash-Flow?

As of today (2024-06-01), NLS Pharmaceutics's share price is $0.141. NLS Pharmaceutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.25. Hence, NLS Pharmaceutics's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for NLS Pharmaceutics's Price-to-Operating-Cash-Flow or its related term are showing as below:

NLSP's Price-to-Operating-Cash-Flow is not ranked ^*
in the Biotechnology industry.
Industry Median: 25.775
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

NLS Pharmaceutics's Cash Flow from Operations per share for the six months ended in Dec. 2023 was $-0.06. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.25.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -60.00% per year. During the past 5 years, the average Operating Cash Flow per Share Growth Rate was -52.70% per year.

During the past 7 years, NLS Pharmaceutics's highest 3-Year average Operating Cash Flow per Share Growth Rate was 48.80% per year. The lowest was -253.20% per year. And the median was -67.75% per year.

NLS Pharmaceutics Price-to-Operating-Cash-Flow Historical Data

The historical data trend for NLS Pharmaceutics's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

NLS Pharmaceutics Price-to-Operating-Cash-Flow Chart

NLS Pharmaceutics Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

NLS Pharmaceutics Semi-Annual Data
	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial								-	-	-	-	-

Competitive Comparison of NLS Pharmaceutics's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, NLS Pharmaceutics's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

NLS Pharmaceutics's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, NLS Pharmaceutics's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where NLS Pharmaceutics's Price-to-Operating-Cash-Flow falls into.

NLS Pharmaceutics Price-to-Operating-Cash-Flow Calculation

NLS Pharmaceutics's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.141	/	-0.254
	=

NLS Pharmaceutics's Share Price of today is $0.141.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. NLS Pharmaceutics's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.25.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

NLS Pharmaceutics Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of NLS Pharmaceutics's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

NLS Pharmaceutics (NLS Pharmaceutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » NLS Pharmaceutics Ltd (NAS:NLSP) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

The Circle 6, Zurich, CHE, 8058

Website

https://www.nlspharma.com

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.